Tim Lee | Senior Director, Investor Relations |
Jan Mikkelsen | President and Chief Executive Officer |
Scott Smith | Senior Vice President and Chief Financial Officer |
Dana Pizzuti | Head, Development Operations and Chief Medical Officer |
Stina Singel | Head, Clinical Development Oncology |
Joe Kelly | Head, U.S. Commercial Endocrinology |
Jessica Fye | JPMorgan |
Josh Schimmer | Evercore |
Tazeen Ahmad | Bank of America |
David Lebowitz | Citibank |
Li Watsek | Cantor |
Vikram Purohit | Morgan Stanley |
Good day and thank you for standing by. Welcome to the Ascendis Pharma Second Quarter 2022 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker for today, Mr. Tim Lee, Senior Director of Investor Relations for Ascendis Pharma.